I Ryabov1. 1. Department of Sociology and Anthropology, The University of Texas-Pan American, 1201 W. University Drive, Edinburg, TX 78539-2999, United States. Electronic address: ryabovi@utpa.edu.
Abstract
OBJECTIVES: This study attempted to evaluate clinical outcomes and long-term cost-effectiveness of an intervention involving Community Health Workers (CHW's, a.k.a. promotoras de salud in Spanish) in assisting Mexican-American diabetes type-2 patients with controlling their condition. The intervention has been carried out in Hidalgo County, TX which is situated on the U.S.-Mexico border. STUDY DESIGN: The design of the study is experimental. The sample (n = 30) was recruited from Mexican-American diabetes patients aged 30 or above. The intervention group received monthly visits from CHW's, while the control group did not. METHODS: Incremental lifetime health outcomes and related expenditures were calculated using the CDC Diabetes Cost-Effectiveness Model (DCEM) which is a probabilistic computer simulation model of disease progression and cost-effectiveness for type 2 diabetes patients. The DCEM allows projection of lifetime healthcare costs and Quality-Adjusted Life-Years (QALYs). RESULTS: The intervention group showed a significant improvement in glycemic control and cholesterol management after two years of intervention. The intervention is expected to reduce long-term complications, resulting in an increase in residual life-years and quality-adjusted life-years. The incremental cost-effectiveness ratio has been estimated to be $13,810, which is below the level of comparable studies. CONCLUSIONS: Intervention has a substantial impact on the medical costs of type 2 diabetes treatment. The estimates presented in this model may be used to analyse the cost-effectiveness of interventions involving CHW's for type 2 diabetes.
OBJECTIVES: This study attempted to evaluate clinical outcomes and long-term cost-effectiveness of an intervention involving Community Health Workers (CHW's, a.k.a. promotoras de salud in Spanish) in assisting Mexican-American diabetes type-2patients with controlling their condition. The intervention has been carried out in Hidalgo County, TX which is situated on the U.S.-Mexico border. STUDY DESIGN: The design of the study is experimental. The sample (n = 30) was recruited from Mexican-American diabetespatients aged 30 or above. The intervention group received monthly visits from CHW's, while the control group did not. METHODS: Incremental lifetime health outcomes and related expenditures were calculated using the CDC Diabetes Cost-Effectiveness Model (DCEM) which is a probabilistic computer simulation model of disease progression and cost-effectiveness for type 2 diabetespatients. The DCEM allows projection of lifetime healthcare costs and Quality-Adjusted Life-Years (QALYs). RESULTS: The intervention group showed a significant improvement in glycemic control and cholesterol management after two years of intervention. The intervention is expected to reduce long-term complications, resulting in an increase in residual life-years and quality-adjusted life-years. The incremental cost-effectiveness ratio has been estimated to be $13,810, which is below the level of comparable studies. CONCLUSIONS: Intervention has a substantial impact on the medical costs of type 2 diabetes treatment. The estimates presented in this model may be used to analyse the cost-effectiveness of interventions involving CHW's for type 2 diabetes.
Authors: Helen E Jack; Sophia D Arabadjis; Lucy Sun; Erin E Sullivan; Russell S Phillips Journal: J Gen Intern Med Date: 2016-12-05 Impact factor: 5.128
Authors: Verughese Jacob; Sajal K Chattopadhyay; David P Hopkins; Jeffrey A Reynolds; Ka Zang Xiong; Christopher D Jones; Betsy J Rodriguez; Krista K Proia; Nicolaas P Pronk; John M Clymer; Ron Z Goetzel Journal: Am J Prev Med Date: 2019-03 Impact factor: 5.043
Authors: Edwin B Fisher; Renée I Boothroyd; Emily A Elstad; Laura Hays; Amy Henes; Gary R Maslow; Clayton Velicer Journal: Clin Diabetes Endocrinol Date: 2017-05-25
Authors: Ann V Millard; Margaret A Graham; Nelda Mier; Jesus Moralez; Maria Perez-Patron; Brian Wickwire; Marlynn L May; Marcia G Ory Journal: Front Public Health Date: 2017-06-12
Authors: Xinyang Hua; Thomas Wai-Chun Lung; Andrew Palmer; Lei Si; William H Herman; Philip Clarke Journal: Pharmacoeconomics Date: 2017-03 Impact factor: 4.981